View in EDS

Oral Ibrexafungerp Outcomes in Subjects With Refractory Vulvovaginal Candidiasis From an Open-Label Study (FURI) [A122].

Saved in:
Bibliographic Details
Title: Oral Ibrexafungerp Outcomes in Subjects With Refractory Vulvovaginal Candidiasis From an Open-Label Study (FURI) [A122].
Authors: Goje, Oluwatosin1 (AUTHOR), King, Thomas (AUTHOR), Angulo, David (AUTHOR), Azie, Nkechi (AUTHOR)
Source: Obstetrics & Gynecology. 2022 Supplement, Vol. 139, p36S-36S. 1p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first